Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This trial is to compare the efficacy, safety and tolerability of Rosuvastatin with
Atorvastatin by assessing the change of LDL-C in patients with hypercholesterolemia and
history of coronary heart disease (CHD) or risk equivalent, or a 10 year CHD risk of no less
than 10%, following 6-week treatment and a possible 6 week extension treatment.